Novartis AG Common Stock (NVS) Total Costs & Expenses & History | Stock Alarm

Demo Sign up Log In

Novartis AG Common Stock · Total Costs & Expenses

NVS Total Costs & Expenses

Latest reported$38.64Bperiod endingJun 30, 2026

NVS Total Costs & Expenses ($18.01B → $38.64B)

Annual Total Costs & Expenses

High-resolution chart · PNG

NVS total costs & expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Total Costs & Expenses — Annual fiscal periods (USD)
Period ending	Total Costs & Expenses (USD)
Dec 31, 2025	37,737,264,000
Dec 31, 2024	37,178,000,000
Dec 31, 2023	36,891,000,000
Dec 31, 2022	35,515,000,000
Dec 31, 2021	33,918,000,000
Dec 31, 2020	39,746,000,000
Dec 31, 2019	39,591,000,000
Dec 31, 2018	37,696,000,000
Dec 31, 2017	34,702,000,000
Dec 31, 2016	41,168,000,000
Dec 31, 2015	41,410,000,000
Dec 31, 2014	42,545,000,000
Dec 31, 2013	41,733,000,000
Dec 31, 2012	40,464,000,000
Dec 31, 2011	48,595,000,000
Dec 31, 2010	40,035,000,000
Dec 31, 2009	35,121,000,000
Dec 31, 2008	33,620,000,000
Dec 31, 2007	32,166,000,000
Dec 31, 2006	27,463,000,000
Dec 31, 2005	23,246,000,000
Dec 31, 2004	21,160,000,000
Dec 31, 2003	19,295,000,000
Dec 31, 2002	15,785,000,000
Dec 31, 2001	14,437,000,000
Dec 31, 2000	17,301,000,000
Dec 31, 1999	15,775,000,000
Dec 31, 1998	18,010,174,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.